Furthermore, we show that ALDH5A1 is downregulated in GBM patients, acts as a tumor suppressor in cell lines, and its high expression correlates with improved patient survival, further strengthening its clinical significance. The gene discussed is ALDH5A1; the disease is glioblastoma.